Attached files

file filename
10-K - 10-K - Altimmune, Inc.d514795d10k.htm
EX-32.2 - EX-32.2 - Altimmune, Inc.d514795dex322.htm
EX-32.1 - EX-32.1 - Altimmune, Inc.d514795dex321.htm
EX-31.2 - EX-31.2 - Altimmune, Inc.d514795dex312.htm
EX-31.1 - EX-31.1 - Altimmune, Inc.d514795dex311.htm
EX-23.2 - EX-23.2 - Altimmune, Inc.d514795dex232.htm
EX-21 - EX-21 - Altimmune, Inc.d514795dex21.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

Form   Registration Number   Date Filed

S-3

S-8

S-8

S-3

S-3

S-8

S-3

S-3

 

333-217034

333-217846

333-214765

333-176607

333-161587

333-156371

333-155692

333-146463

 

3/30/2017

5/10/2017

11/22/2016

9/1/2011

8/27/2009

12/19/2008

11/25/2008

10/2/2007

of our report dated March 30, 2018, with respect to the consolidated financial statements of Altimmune, Inc,, included in this Annual Report (Form 10-K) of Altimmune, Inc. for the year ended December 31, 2017.

/s/ Ernst & Young LLP

Baltimore, Maryland

March 30, 2018